ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc. |
| [21-February-2025] |
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by bluebird bio, Inc. (NASDAQ: BLUE) and its board of directors concerning the proposed acquisition of the company by Carlyle (NASDAQ: CG) and SK Capital Partners, LP. Stockholders will receive $3.00 and a contingent value right of $6.84 for each share of bluebird bio stock that they hold. The transaction is expected to close in the first half of 2025. If you are a stockholder of bluebird bio, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/blue/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free). Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC | ||
Company Codes: NASDAQ-NMS:BLUE, NASDAQ-NMS:CG |
View original content:
